Detalhe da pesquisa
1.
Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative.
Br J Cancer
; 124(9): 1503-1512, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33597715
2.
A multicentre analytical comparison study of inter-reader and inter-assay agreement of four programmed death-ligand 1 immunohistochemistry assays for scoring in triple-negative breast cancer.
Histopathology
; 78(4): 567-577, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32936950
3.
Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).
Eur Radiol
; 31(8): 5880-5893, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34052881
4.
Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines.
Ann Intern Med
; 172(1): 46-56, 2020 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31766052
5.
[Updated WHO classification of tumors of the breast]. / Aktualisierte WHO-Klassifikation der Tumoren der Mamma.
Pathologe
; 42(Suppl 2): 155-159, 2021 Dec.
Artigo
em Alemão
| MEDLINE | ID: mdl-34751805
6.
[Updated WHO classification of tumors of the breast: the most important changes]. / Aktualisierte WHO-Klassifikation der Tumoren der Mamma: Die wichtigsten Änderungen.
Pathologe
; 42(3): 270-280, 2021 May.
Artigo
em Alemão
| MEDLINE | ID: mdl-33822251
7.
Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators.
BMC Cancer
; 20(1): 795, 2020 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32831048
8.
Development and use of health outcome descriptors: a guideline development case study.
Health Qual Life Outcomes
; 18(1): 167, 2020 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32503619
9.
Methods for Development of the European Commission Initiative on Breast Cancer Guidelines: Recommendations in the Era of Guideline Transparency.
Ann Intern Med
; 171(4): 273-280, 2019 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31330534
10.
An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®.
Breast Cancer Res
; 19(1): 55, 2017 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28490348
11.
Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer.
N Engl J Med
; 381(13): 1289-1290, 2019 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31553845
12.
Assessing HER2 testing quality in breast cancer: variables that influence HER2 positivity rate from a large, multicenter, observational study in Germany.
Mod Pathol
; 30(2): 217-226, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27767099
13.
Correction to: Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).
Eur Radiol
; 32(6): 4333, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34994847
14.
Updates in the treatment of ductal carcinoma in situ of the breast.
Curr Opin Obstet Gynecol
; 28(1): 49-58, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26694830
15.
Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.
Nat Genet
; 39(5): 655-60, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17417639
16.
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.
Lancet Oncol
; 14(7): 609-18, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23683750
17.
[B3 lesions of the breast: histological, clinical, and epidemiological aspects : Update]. / B3-Läsionen der Mamma: Histologische, klinische und epidemiologische Aspekte : Update.
Pathologie (Heidelb)
; 44(1): 5-16, 2023 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-36635403
18.
New treatment options for metastatic HER2-low breast cancer : Consequences for histopathological diagnosis.
Pathologie (Heidelb)
; 44(Suppl 2): 53-60, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36472635
19.
[Immunohistology in breast diagnostics : Strategies for efficient diagnostics]. / Immunhistologie in der Mammadiagnostik : Strategien für effiziente Diagnostik.
Pathologie (Heidelb)
; 44(1): 17-31, 2023 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-36576522
20.
[Clinically relevant molecular pathological diagnostics in breast cancer]. / Klinisch relevante molekularpathologische Diagnostik beim Mammakarzinom.
Pathologie (Heidelb)
; 44(1): 39-49, 2023 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-36629894